SOMAPURE by Meditech is a pharmaceutical-grade recombinant Human Growth Hormone (somatropin) injectable formulation, available in a pack of 10 vials at 10 IU per vial for a total of 100 IU per pack. Somatropin is a 191-amino acid recombinant DNA-derived growth hormone with an extensive clinical and pharmacological research history, investigated across a broad spectrum of endocrinological, metabolic, and regenerative medicine applications.
 
✔ Key Research Insights
Studied for its role in stimulating hepatic IGF-1 production, with documented downstream effects on muscle tissue regeneration, protein synthesis, and cellular repair mechanisms in research subjects
Investigated for its influence on metabolic parameters including lipolysis and fat oxidation, with documented effects on body composition indices across clinical research populations
Researched for its effects on recovery markers, musculoskeletal repair, and connective tissue regeneration including tendon and joint parameters in documented subject populations
Examined for its influence on bone mineral density and skeletal integrity via IGF-1 mediated anabolic signaling in clinical observations
Documented for its effects on sleep architecture quality, with growth hormone secretion patterns and deep sleep phase parameters investigated across neuroendocrinological research literature
Researched for its effects on skin collagen synthesis and dermal cellular regeneration parameters in clinical observations
Manufactured by Meditech to pharmaceutical-grade purity and potency standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: SOMAPURE
Molecule: Somatropin (Human Growth Hormone, 191 amino acid sequence)
Concentration: 10 IU per vial
Volume: 10 vials per pack (100 IU total)
Form: Injectable lyophilized powder requiring reconstitution prior to administration
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
Somatropin is a recombinant DNA-derived human growth hormone consisting of a 191-amino acid chain identical in structure to endogenous pituitary-derived HGH. Following subcutaneous or intramuscular administration in research subjects, somatropin acts on growth hormone receptors in the liver and peripheral tissues, stimulating the production of insulin-like growth factor 1 (IGF-1) — the primary downstream mediator of growth hormone activity throughout the body. IGF-1 subsequently activates anabolic signaling pathways in muscle, bone, and connective tissue, with documented effects on protein synthesis, nitrogen retention, cellular proliferation, and tissue repair in clinical research populations. Independent of IGF-1 mediation, somatropin also exerts direct lipolytic effects on adipose tissue through growth hormone receptor activation, stimulating triglyceride breakdown and fatty acid oxidation as documented in metabolic research literature. Additional areas of clinical research interest documented for somatropin include its effects on bone mineral density via osteoblast stimulation, collagen biosynthesis in dermal and connective tissues, and the well-established relationship between growth hormone secretion and slow-wave sleep architecture in neuroendocrinological research. Due to its peptide nature, somatropin is not orally bioavailable and requires subcutaneous or intramuscular injection as the route of administration across all documented clinical protocols.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and potency standards
Recombinant DNA-derived somatropin formulation with a 191-amino acid sequence identical to endogenous human growth hormone
Clinically established compound with documented indications and research applications spanning endocrinology, metabolic medicine, and regenerative research
Supplied in a 10-vial pack format providing 100 IU total, supporting extended research and clinical administration protocols
Widely referenced in endocrinological and clinical research literature under the somatropin and human growth hormone designations worldwide